Navigation Links
Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide in Chronic Heart Failure Patients
Date:10/18/2011

www.nilethera.com.

Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Nile's plans to develop cenderitide in the post-acute setting, the anticipated benefits of cenderitide for patients in the post-acute setting, Nile's understanding of the preliminary data from the Phase I study, Nile's plans for further development of cenderitide and its ability to fund such development, Nile's ability to obtain FDA approval of cenderitide in the post-acute setting and Nile's beliefs about the potential impact of a decrease of the ADHF re-hospitalization rate on the quality of life for patients, are forward-looking statements. Forward-looking statements also include statements regarding the timing, progress and anticipated results of the clinical development, regulatory processes, clinical trial timelines, expected patient enrollment, anticipated benefits of cenderitide, Nile's strategy, future operations, outlook, milestones, the timing and success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Nile makes. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that Nile makes include Nile's need to obtain additional capital to fund its product development programs to completion, Nile's reliance on third-party resea
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Cardinal Health Selects Datameer for Healthcare Data Discovery 2
... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced ... on Tuesday, November 1, 2011 at 4:30 p.m. Eastern Time/1:30 ... a business and financial update and review third quarter 2011 ... may be accessed from the Investors section of the Jazz ...
... Genprex, Inc. announced today that it will be presenting ... in San Francisco.   Greg Heinlein , Chief Operating and Financial ... Investor Forum , on October 25 starting at 11 a.m. PDT ... will be made available on the company,s website under the News ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2
(Date:5/23/2013)... 23, 2013) Treating pediatric leukemia patients with a ... dose during initial treatment may result in high survival ... the results of a study published online ... of the American Society of Hematology (ASH). ... common form of leukemia in children, is a blood ...
(Date:5/23/2013)... Henry Ford Hospital found "substantial evidence" that a regenerative ... could hold the key to better functional recovery by ... to those who suffer stroke, the leading cause of ... some ability to voluntarily use their hands and other ... one side of their bodies, while a substantial number ...
(Date:5/23/2013)... Alachua, FL (PRWEB) May 23, 2013 ... leading regenerative medicine company focused on the commercialization ... reconstruction and regeneration, today announced that the Company ... $1.1 million grant, for which AxoGen’s portion is ... Programs administrated by the U.S. Department of Defense ...
(Date:5/23/2013)... May 23, 2013 Hile Design LLC ... firm was awarded a Silver Creative Award at the ... The winning entry was for its “Open Doors” animation ... of Show” in the 2013 District 6 ADDY Awards ... The Summit Creative Award recognizes and celebrates the creative ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
Breaking Medicine News(10 mins):Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 2Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 3Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 2Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 3Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2
... ... USA offers two for one deal on summits. Also book your room before the ... ... Biopolymers Symposium 2009 conference and exhibit, taking place at the Embassy Suites Downtown Lakefront, in ...
... , , , ... Tim Gunn, television host and fashion consultant ("Project Runway," "Tim Gunn,s Guide ... the Ad dressing Psoriasis(TM) Fashion Show, sponsored by Amgen and Wyeth, ... severe plaque psoriasis who have not allowed the condition to inhibit their ...
... greater alcohol consumption, study shows , WEDNESDAY, Sept. 2 (HealthDay ... intoxicated students and more health and safety problems, new research ... and the results can be injury, violence and even death. ... at college bars and found that cheap drinks come with ...
... before 65, study finds, many younger patients not getting ... could be affecting Americans earlier in life than ever ... longer an affliction of old age," said lead researcher ... neurology and investigator for the Cognitive Rehabilitation Research Group ...
... , , MURRIETA, Calif., ... its ABTTC Inc. division, provides drug and alcohol rehabilitation and ... levels of accreditation, announced today that its co-founder and CEO, ... Company,s recent successes, management team and shareholder relations. , ...
... , Pfizer to Pay $2.3 Billion ... Sept. 2 American pharmaceutical giant Pfizer Inc. and its subsidiary ... pay $2.3 billion, the largest health care fraud settlement in the ... liability arising from the illegal promotion of certain pharmaceutical products, the ...
Cached Medicine News:Health News:Biopolymers Symposium 2009 Offers Two for One Deal: Attend Retailers Scorecard Seminar and Attend the EcoLabeling Summit Free 2Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 2Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 3Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 4Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 5Health News:College Students Get More Drunk When Drinks Are Cheap 2Health News:Stroke May Be Striking at a Younger Age 2Health News:Stroke May Be Striking at a Younger Age 3Health News:Forterus Inc. Treatment Centers Showing Consistent, Sustainable Growth; CEO Paul Howarth Interviewed 2Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 2Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 3Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 4Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 5Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 6
... The White Sun light source offers the industry ... Kelvin color temperature at a lower price. A ... White Sun to be used with Olympus, Storz, ... light output LED and re-settable bulb timer. The ...
... The NGAL ELISA Kit is intended for ... (e.g. plasma, serum, urine), tissue extracts or ... dramatically increased, especially in urine, as early ... in ongoing renal repair processes. NGAL expression ...
... Light Head is clearly the favorite for ... 36-inch arms, the dual light heads rotate ... stability, providing unlimited positioning. Engineered construction prevents ... ranging from minimally invasive through trauma to ...
... offers all the performance of a major surgical ... use in Outpatient Settings, Minor Procedure Rooms, C-Section, ... single lights either side of the OR table ... General OR when combining Flat Screen LCD Monitors ...
Medicine Products: